We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Richardson Electronics
RELL
$304M
| $193K | ﹤0.01% |
14,445
-186
| -1% | -$2.22K |
|
3027
Virginia National Bankshares
VABK
$260M
| $193K | ﹤0.01% |
5,608
-90
| -2% | -$2.96K |
|
3028
Seres Therapeutics
MCRB
$48.4M
| $193K | ﹤0.01% |
6,876
+48
| +0.7% | +$1.26K |
|
3029
Princeton Bancorp
BPRN
$287M
| $192K | ﹤0.01% |
5,358
-124
| -2% | -$4.02K |
|
|
VTYX
3030
DELISTED
Ventyx Biosciences
VTYX
| $191K | ﹤0.01% |
77,482
+12,853
| +20% | +$122K |
|
3031
Biglari Holdings Class B
BH
$1.21B
| $191K | ﹤0.01% |
1,160
| – | – |
|
3032
Aveanna Healthcare
AVAH
$2.07B
| $191K | ﹤0.01% |
71,337
-675
| -0.9% | -$1.29K |
|
|
LOGC
3033
DELISTED
ContextLogic
LOGC
| $191K | ﹤0.01% |
32,102
+30
| +0.1% | +$146 |
|
|
PHLT
3034
DELISTED
Performant Healthcare Inc
PHLT
| $190K | ﹤0.01% |
60,853
-872
| -1% | -$2.29K |
|
|
AOMR
3035
Angel Oak Mortgage REIT
AOMR
$209M
| $190K | ﹤0.01% |
17,935
-110
| -0.6% | -$1.04K |
|
3036
WPP
WPP
$5.94B
| $190K | ﹤0.01% |
3,996
+97
| +2% | +$4.34K |
|
3037
First Community Corp
FCCO
$322M
| $190K | ﹤0.01% |
8,812
-118
| -1% | -$2.16K |
|
3038
Core Molding Technologies
CMT
$234M
| $189K | ﹤0.01% |
10,209
+292
| +3% | +$6.38K |
|
3039
Mayville Engineering Co
MEC
$617M
| $189K | ﹤0.01% |
13,097
-171
| -1% | -$2.12K |
|
3040
Vuzix
VUZI
$224M
| $188K | ﹤0.01% |
90,173
-2,150
| -2% | -$5.86K |
|
|
MACK
3041
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $187K | ﹤0.01% |
13,951
+72
| +0.5% | +$910 |
|
3042
PMV Pharmaceuticals
PMVP
$63.5M
| $185K | ﹤0.01% |
59,748
-1,646
| -3% | -$4.36K |
|
|
SBDS
3043
DELISTED
Solo Brands Inc
SBDS
| $184K | ﹤0.01% |
749
-12
| -2% | -$2.34K |
|
3044
National Bankshares
NKSH
$268M
| $184K | ﹤0.01% |
5,700
-214
| -4% | -$5.75K |
|
3045
Century Casinos
CNTY
$34M
| $182K | ﹤0.01% |
37,370
-49
| -0.1% | -$226 |
|
|
NJ
3046
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $182K | ﹤0.01% |
18,030
-210
| -1% | -$2.12K |
|
3047
Compass Therapeutics
CMPX
$387M
| $182K | ﹤0.01% |
116,532
-587
| -0.5% | -$1.02K |
|
3048
The Joint Corp
JYNT
$119M
| $181K | ﹤0.01% |
18,864
+101
| +0.5% | +$875 |
|
|
ACH
3049
DELISTED
Alum Corp of China Ltd
ACH
| $181K | ﹤0.01% |
17,865
| – | – |
|
|
GRFS
3050
Grifois
GRFS
$5.4B
| $180K | ﹤0.01% |
15,611
+6,795
| +77% | +$63.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.